After 14 days of treatment, 64.6% of the patients taking ... More information: Jun Hamano et al, Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind ...

Exclusion criteria included fecal impaction, mechanical bowel obstruction, constipation not attributed to postprocedure opioid use, calculated creatinine clearance less than 50 mL/min, and ...

I have several comments: Every textbook stresses the importance of routine early administration of laxatives when opioid treatment is started, in order to treat any constipation—a common side ...

albeit off-label use for methylnaltrexone—that being for the treatment of acute constipation that occurs as a consequence of postoperative opioid-mediated analgesia in patients following ...

Here, we report the preventive effect of naldemedine versus placebo for constipation in patients with cancer starting an opioid therapy in a multicenter ... We conducted rigorous safety assessments on ...

Opiate induced constipation is undoubtedly ... Müller-Lissner S: The pathophysiology, diagnosis and treatment of constipation [Obstipation – Pathophysiologie, Diagnose und Therapie].

Are you searching for medications to treat 'Constipation'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Constipation. The page includes ...

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...

Rizmoic is a once-daily 200-microgram oral tablet for the treatment of opioid induced constipation (OIC) in adult patients previously treated with a laxative. Shionogi received EU marketing ...

Rizmoic is a once-daily 200-microgram oral tablet for the treatment of opioid induced constipation (OIC) in adult patients previously treated with a laxative. Shionogi received EU marketing ...

"These safe, effective, and powerful medications continue to transform the treatment of opioid use disorder, offering a convenient and reliable way to deliver consistent steady state doses of ...